Christine M. Cunningham, Professor at The Pennsylvania State University, discusses engineering solutions for children to help solve ecological problems
Phil Evans, EIDO’s Director of Partnerships, writes about the crucial importance of collaborative solutions in digital health and the healthcare sector.
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Joe Miller, Pocketalk General Manager of the Americas and Europe, explores how language and communication barriers affect UK government organisations & the solutions available.
Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.
Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
Rob Irons, Senior Manager at Hinduja Global Solutions, discusses whether public sector customer service has improved with the adoption of cloud technology.
Eugene M. Terentjev, a professor of Polymer Physics at the University of Cambridge looks at smart, reusable adhesion through liquid crystalline elastomers.
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
The majority of businesses supplying products and services into the NHS through surgical pathways cannot have failed to be aware of the declared intent by the NHS to decarbonise the health system.
